Bio-Techne
TECH
#2187
Rank
C$12.47 B
Marketcap
C$79.75
Share price
-1.82%
Change (1 day)
-14.61%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): C$0.73

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is C$0.71. In 2024 the company made an earnings per share (EPS) of C$1.37 a decrease over its 2023 EPS that were of C$1.94.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.73-46.79%
2024C$1.37-29.58%
2023C$1.94-14.97%
2022C$2.2924.16%
2021C$1.8417.98%
2020C$1.56-10.94%
2019C$1.75101.57%
2018C$0.87-16.99%
2017C$1.0545.02%
2016C$0.72-20.97%
2015C$0.91-14.97%
2014C$1.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$24.33 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$7.63 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$11.25 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$6.94 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.69 278.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
C-$0.29-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C-$33.28-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA